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ABSTRACT: Cys accessibility and quantitative intact mass spectrom-
etry (MS) analyses have been devised to study the topological transitions
of Mhp1, the membrane protein for sodium-linked transport of
hydantoins from Microbacterium liquefaciens. Mhp1 has been crystallized
in three forms (outward-facing open, outward-facing occluded with
substrate bound, and inward-facing open). We show that one natural
cysteine residue, Cys327, out of three, has an enhanced solvent
accessibility in the inward-facing (relative to the outward-facing) form.
Reaction of the puriﬁed protein, in detergent, with the thiol-reactive N-
ethylmalemide (NEM), results in modiﬁcation of Cys327, suggesting
that Mhp1 adopts predominantly inward-facing conformations. Addition
of either sodium ions or the substrate 5-benzyl-L-hydantoin (L-BH) does
not shift this conformational equilibrium, but systematic co-addition of
the two results in an attenuation of labeling, indicating a shift toward
outward-facing conformations that can be interpreted using conventional enzyme kinetic analyses. Such measurements can aﬀord
the Km for each ligand as well as the stoichiometry of ion−substrate-coupled conformational changes. Mutations that perturb the
substrate binding site either result in the protein being unable to adopt outward-facing conformations or in a global
destabilization of structure. The methodology combines covalent labeling, mass spectrometry, and kinetic analyses in a
straightforward workﬂow applicable to a range of systems, enabling the interrogation of changes in a protein’s conformation
required for function at varied concentrations of substrates, and the consequences of mutations on these conformational
transitions.
Secondary active membrane transport proteins exploit thepotential energy of ion gradients (e.g., proton or sodium)
to drive the transport of solutes across membranes.1 The
available structures of these proteins (and other biophysical
analyses) suggest a common transport mechanism, termed
alternating access, whereby substrate/ion binding sites on the
two sides of the membrane are alternately exposed.2−6
Substrate binding on one side of the membrane leads to
conformational changes that enable its release on the other
side. Movements of transmembrane helices as well as external/
internal helices and loops underlie this alternating access
mechanism. The conformational state(s) of such proteins can
be determined by means of X-ray crystallography, but
elucidating the conformational state(s) and intermediates
adopted in solution, and how the binding of ligands inﬂuences
the conformational equilibrium of the protein, is of vital
importance to enable full characterization of the transport
cycle.7−10
Mass Spectrometry (MS) is being employed increasingly for
the structural interrogation of proteins and protein assem-
blies,11−14 with recent methodological advances permitting the
analysis of membrane proteins (MPs).15 Noncovalent MS can
be employed to determine the stoichiometry of MP
assemblies,16−18 observe protein binding to lipids and small
molecules,19,20 and study conformational changes upon binding
(when coupled with ion mobility spectrometry).21,22 Chemical
cross-linking MS, where a bifunctional small molecule is used to
chemically join spatially proximal residues, can be used to aﬀord
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low residue distance restraints for the modeling of protein
complex architecture and conformational changes.23−27 Map-
ping of solvent accessibility and dynamics can also be
performed by implementing well-established covalent labeling
workﬂows, including hydrogen−deuterium exchange,28,29 hy-
droxyl radical footprinting,30,31 carbene labeling,32,33 and amine
reactivity.23,24 Additionally, reaction of Cys residues with
maleimides, such as N-ethylmaleimide (NEM), which react
with the thiol group of Cys residues by Michael addition, has
been successfully implemented to interrogate Cys residue
accessibility and to deduce conformational/topological in-
formation.9,34,35
The transport protein Mhp1 from Microbacterium liquefaciens
(M. liquefaciens) mediates the uptake of 5-aryl-substituted
hydantoins in a Na+-dependent fashion.36,37 Mhp1 is a member
of the nucleobase−cation−symport-1 (NCS-1) family of
secondary active transport proteins [part of the amino acid−
polyamine−organocation (APC) superfamily], which is found
widely in bacteria, archaea, fungi, and plants.2,7,38−41 NCS-1
family proteins are structurally related by a 5-helix/5-helix
internal pseudosymmetry to proteins in diﬀerent subfamilies of
the APC superfamily, which is also called the 5-helix inverted
repeat (5HIRT) or LeuT superfamily of ion-coupled trans-
porters. In humans, membrane transport proteins of these
families are involved in processes such as neurotransmitter,
sugar, amino acid, and drug transport.42−44 The diversity of
their biological functions has led to a burgeoning ﬁeld of
research pertaining to unravelling the structural basis by which
this class of proteins transport their assorted substrates.2−4,6
Importantly, structures of proteins in the 5HIRT/LeuT
superfamily diﬀer completely from those in the major facilitator
superfamily, a small number of which have been studied by MS
previously.35,45
Mhp1 contains 12 transmembrane helices (TMHs), with 10
core TMHs, characteristic of the 5HIRT superfamily, and two
additional C-terminal helices.48 Structures of Mhp1 in the
outward-open, inward-open, and occluded states (Figure 1a)
have been solved by X-ray crystallography.46−48 TMHs 1, 2, 6,
and 7 form a four helix bundle (Figure 1a, red helices), and
TMHs 3, 4, 8, and 9 form a motif that resembles a hash sign
(#) (Figure 1a, yellow helices).46 The ligand and Na+ binding
sites are located between the hash and bundle motifs and
involve residues in TMHs 1 and 6 (where the helices break).
Binding of the ligand to the outward-facing conformation
causes TMH 10 to bend and occlude the substrate binding site;
a subsequent transition to the inward-facing conformation
occurs as a result of movement of the hashed domain relative to
the bundle domain.46,48
Here we combine Cys-accessibility determination by NEM
reactivity, intact MS analysis, peptide mapping, and localization
of NEM modiﬁcation sites to gain insights into the topological
states of Mhp1. The data suggest that detergent-solubilized
Mhp1 adopts predominantly inward-facing conformations and
that the presence of either Na+ or the substrate L-BH does not
shift this conformational equilibrium. However, co-addition of
both Na+ and L-BH results in the outward-facing conformation
being populated signiﬁcantly. By titrating in various combina-
tions of L-BH/Na+, we demonstrate that the data obtained can
be used to extract the stoichiometry of binding which induces
the conformational change. We also demonstrate the suitability
of the method to characterize variants of Mhp1 and provide a
rationale for mutation-induced changes in substrate binding
eﬃciency. Additionally, we show that the approach can be used
to screen ligands and identify binders.
We envisage that the workﬂow developed will be widely
transferrable and provide insights into membrane transport
proteins and other protein systems, including (i) the conforma-
tional states adopted under diﬀerent conditions; (ii) identifying
and characterizing binding of (novel) substrates and inhibitors
(by using the MS method as a library screening tool); and (iii)
characterizing variants to determine whether they have the
same conformational ﬁngerprint as the wild-type protein.
■ EXPERIMENTAL SECTION
Expression and Puriﬁcation of Mhp1 and Mhp1
Variants. Throughout the text, wild-type Mhp1 indicates the
protein modiﬁed by the addition of a C-terminal His6 tag.
37
Expression and puriﬁcation of Mhp1 and Mhp1 variants was
conducted as described previously.36,37,47−49
Figure 1. X-ray crystal structures of Mhp1. (a) X-ray crystal structures of Mhp1 in the inward-facing (Protein Data Bank (PDB) 2X79),46 outward-
occluded (PDB 4D1B),47 and outward-facing (PDB 2JLN)48 conformations. Helices are represented as cylinders. The bundle46 helices (TMHs 1, 2,
6, and 7) are colored red, the hash46 motif helices (TMHs 3, 4, 8, and 9) are colored yellow, the ﬂexible helices (TMHs 5 and 10) are colored blue,
the C-terminal helices (TMHs 11 and 12) and the surface extracellular and cytoplasmic helices are colored gray. The Cys residues are shown in cyan.
(b, c) Location of Cys327 (cyan) in the (b) inward-facing and (c) outward-facing conformations of Mhp1, showing that TMH9 protects Cys327
from solvent in the outward-facing conformation. (d) Average side-chain solvent-accessible surface area (SASA) values of the three Cys residues of
Mhp1 in 20 ns MD simulations started from the inward-facing (IF), outward-occluded (OOc), and outward-facing (OF) crystal structures.
Analytical Chemistry Article
DOI: 10.1021/acs.analchem.7b01310
Anal. Chem. 2017, 89, 8844−8852
8845
Labeling of Mhp1 with N-Ethylmaleimide. Solutions of
puriﬁed Mhp1 (10 μM) in 10 mM Tris-HCl (pH 8), 2.5% (v/
v) glycerol, 0.05% (w/v) DDM, and 2% (v/v) DMSO were
supplemented with one or more of the following (see ﬁgure
legends): 15-crown-5 (1.25 mM), NaCl (15, 140, or 1000
mM), choline chloride (125 mM, with 15 mM NaCl), and/or
L-BH (2 mM). The protein was incubated with the appropriate
additives for 10 min before labeling. NEM (1 mM ﬁnal
concentration) was added, and the solution was incubated for 1
h at 25 °C. The reaction was quenched by adding DTT (ﬁnal
concentration of 30 mM) and then incubating at 25 °C for 10
min.
Preparation of Samples for Mass Spectrometry. A
sample of Mhp1 (unlabeled or labeled with NEM) (50 uL, 10
μM) was taken, and methanol (150 μL) and chloroform (50
μL) were added. The solution was mixed by vortexing, water
(100 μL) was added, and the solution was mixed again before
centrifuging (10000g, 2 min). The upper aqueous phase was
carefully removed (leaving the white protein pellet and the
lower organic phase), and methanol (150 μL) was then added.
The solution was mixed by vortexing, centrifuged (10000g, 2
min), and the supernatant removed. The precipitated protein
was air-dried in a laminar ﬂow hood. The dried protein pellet
was resuspended in formic acid (4 μL), and ddH2O was then
added (46 μL) for subsequent MS analyses.
Measurement of the Intact Mass of Mhp1. Proteins
were analyzed intact using online desalting LC-MS on a
nanoAcquity LC system interfaced to a Xevo G2-S mass
spectrometer (Waters Ltd., Wilmslow, Manchester, U.K.).
Deconvolution was performed using UniDec.50 All expected
and observed protein masses are shown in Table S1. See
Supporting Information for details.
Proteolysis and Localization of the Reaction Sites for
NEM in Individual Peptides. Mhp1 was digested by adding
pepsin (at a 1:50 protease:substrate mass ratio) and incubating
at 37 °C for 2 h with shaking. The protease was deactivated by
boiling at 100 °C for 10 min. Peptides were then analyzed by
LC-MS/MS on a nanoAcquity LC system interfaced to a
Synapt G2-Si HDMS mass spectrometer (Waters, U.K.). See
Supporting Information for details.
Mhp1 Ligand Binding Assays. The ability of Mhp1 to
bind L-BH was determined by means of ﬂuorescence emission
spectroscopy on a QuantaMaster spectro-photoﬂuorometer
(Photon Technology International, Ford, West Sussex, U.K.),
using previously published methods.37,47,48,51 See Supporting
Information for details.
Calculation of the Solvent-Accessible Surface Area of
Modiﬁed Residues. Trajectories of 20 ns all-atom molecular
dynamics simulations in an explicit membrane and solvent
environment of inward-facing (IF), outward-facing, and
occluded with both the substrate and Na+ bound (OOc) and
outward-facing with Na+ bound (OF) MhpI were obtained
from a previous study.52 From the coordinates of frames saved
in increments of 1 ps, the average SASA of Cys69, Cys234, and
Cys327 was computed. The SASA of a residue (Ai) was
calculated as the sum of the solvent accessibilities of the
individual side-chain atoms (ai).
∑=
‐
A aI
i
N
i
side chainatoms
The atom-wise solvent-accessible surface area ai was
calculated analytically as described previously.53
■ RESULTS AND DISCUSSION
Cys Residues in Mhp1 Predicted To Have Diﬀerent
Solvent Accessibilities. The available structures of Mhp1
show that Cys327 (located in TMH 8, Figure 1) is located near
the surface of the protein whereas Cys234 and Cys69 are
buried within its structure (Figure 1a). Further comparisons of
the position of Cys327 in the inward-facing open conformation
(Protein Data Bank (PDB) 2X79)46 to its position in the
outward-facing open form (PDB 2JLN)48 suggest that it
becomes relatively protected from solvent in the outward-facing
conformation via reorganization of TMH 9 (Figure 1b,c). To
determine the accessibility of Cys residues in Mhp1, the
residue-speciﬁc side-chain solvent-accessible surface area values
were determined in silico from available molecular dynamics
simulations in explicit membrane and solvent environments
(Figure 1d).52 The analysis showed that the most accessible
Cys residue in all three conformations of Mhp1 is Cys327,
while the other two Cys residues (Cys69 and Cys234) are more
protected from solvent (Figure 1d). In addition, Cys327 is
more highly accessible in the inward-facing relative to the
outward-facing conformation (Figure 1d). Combined, all these
observations suggest that the accessibility of Cys327 could be a
useful probe for discriminating between the inward-facing and
outward-facing conformational states of Mhp1.
Cys327, a Conformationally Sensitive Residue. Follow-
ing incubation of Mhp1 with (or without) NEM (Figure 2a),
electrospray ionization mass spectra of the proteins were
obtained (Figure 2b and Figure S1) and the spectra
deconvoluted (Figure 2c). In the absence of Na+ (ensured by
adding the crown ether 15-crown-5 to sequester residual Na+),
the predominant species observed corresponds to Mhp1 +
1NEM, with minimal unlabeled Mhp1 remaining and negligible
Mhp1 + 2NEM and Mhp1 + 3NEM detected (Figure 2c, lower
panel). The modiﬁed protein was digested with pepsin, and the
Figure 2. Mass spectrometry of wild-type Mhp1 and wild-type Mhp1
labeled with NEM. (a) Reaction of a Cys residue in Mhp1 with NEM,
resulting in a mass addition of 125 Da. (b) Portion of a representative,
unprocessed mass spectrum of Mhp1 (upper panel) and of NEM-
labeled Mhp1 that was preincubated with 15-crown-5 to remove
residual NaCl (lower panel). Spectra were obtained by online
desalting-MS, and only three charge states are shown for clarity; the
full unprocessed spectra are shown in Figure S1. (c) Deconvoluted
mass distributions of labeled and unlabeled Mhp1 (spectra are shown
next to their unprocessed counterpart in panel b). The shading
indicates expected masses of unlabeled and labeled Mhp1.
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modiﬁcation site was localized by peptide mapping. This
conﬁrmed that Cys327 was the dominant residue modiﬁed
(Figure S2), and that the other two Cys residues were only
modiﬁed to a very low level (<1% relative abundance).
Inﬂuence of Hydantoin and Na+ Binding on Cys
Accessibility. To determine the eﬀect (if any) of solution
conditions on the labeling reaction, Mhp1 was preincubated
with NaCl, the ligand L-BH, or a combination of both, before
NEM was added. Intriguingly, the mass distributions obtained
for Mhp1 that was labeled in the presence of either 140 mM
NaCl or 2 mM L-BH were identical to those obtained in the
absence of these species (Figure 3a(i).). Conversely, co-
incubation with both 140 mM NaCl and L-BH resulted in a
dramatically diﬀerent distribution of masses, with both
unlabeled Mhp1 and Mhp1 + NEM identiﬁed, now with
comparable intensity (Figure 3a(i)). Increasing the NaCl
concentration to 1 M and performing the NEM labeling
reactions resulted in the same labeling pattern as in the
presence of 140 mM NaCl (Figure 3b(i)). Again, both 1 M
NaCl and 2 mM L-BH were required to observe a diminution
in labeling, and the proportion of labeled Mhp1 was reduced
further than with 140 mM NaCl (Figure 3b(i)). The modiﬁed
Cys residue in all cases was identiﬁed as Cys327 using
proteolysis and peptide mapping (e.g., see Figure S2).
These data, combined with the structural and SASA data
presented (Figure 1), suggest that addition of either Na+ or L-
BH is insuﬃcient to shift the conformational equilibrium of
Mhp1. Thus, the inward-facing conformation is favored, as in
their absence. However, the synergistic eﬀect of both Na+ and
L-BH together results in conformational conversion to a form
of the protein in which Cys327 is protected from solvent,
consistent with an alteration in the equilibrium so that the
outward-facing conformation becomes favored.
In order to perform a semiquantitative analysis, the relative
intensities of peaks corresponding to unmodiﬁed Mhp1 and
Mhp1 modiﬁed with a single NEM label were determined
(Figure 3a(ii),b(ii)). These measurements reinforce the
conclusion that adding either NaCl or L-BH alone does not
signiﬁcantly alter Mhp1 modiﬁcation by NEM; however, co-
addition of NaCl and L-BH leads to a signiﬁcant shift in
population toward unmodiﬁed Mhp1. Intriguingly, the amount
of unmodiﬁed Mhp1 observed in the presence of 140 mM
NaCl/2 mM L-BH (52.2 ± 5%) is signiﬁcantly lower than that
observed in the presence of 1 M NaCl/2 mM L-BH (68.2 ±
1%). The observation that signiﬁcantly more protein remains
unlabeled in the presence of higher concentrations of NaCl
suggests that the conformational equilibrium of Mhp1 is shifted
even further to the outward-facing form by higher NaCl
concentrations. From these data we propose that the mass
distribution after NEM labeling can be used as a conformational
“ﬁngerprint” to deduce the conformational state of the protein
under varied conditions of Na+ and ligand concentrations.
Speciﬁcity for Substrates of the Protection against
Labeling with NEM. We tested other known ligands of
Mhp147 to determine whether they produced eﬀects similar to
L-BH. Indeed, 5-indolylmethyl-L-hydantoin (L-IMH), 5-(2-
naphthylmethyl)-L-hydantoin (L-NMH), and 5-bromovinylhy-
dantoin (BVH) in solution at a concentration of 2 mM in the
presence of 140 mM Na+ resulted in a reduction in NEM
labeling to approximately similar extents (Figure S3) as that of
L-BH (Figure 3a), while addition of ligand alone had no eﬀect
(Figure S3). Importantly, we also tested the molecules
hydantoin and allantoin, which do not bind to Mhp1.47 In
the presence of these smaller molecules, the labeling of Mhp1 is
not attenuated, consistent with a lack of binding to Mhp1, and
no eﬀect on conformation (Figure S3). Thus, in the presence of
Na+, all ligands that are already known to bind to Mhp1
promote conversion of Mhp1 from the inward-facing to the
outward-facing form. This NEM-MS method could be used
therefore as a rapid screen for new ligands of transporters or for
understanding allosteric switching in other proteins. Perhaps
most appealing, the quantitative and direct readout of the
population of diﬀerent (NEM-accessible and -inaccessible)
states, provides advantages over other methods used for such
binding studies by avoiding the use of radioisotope-labeled
candidates, reducing the amount of protein required (compared
with e.g., ITC), and the need for protein immobilization (SPR)
which can compromise function.
The failure of L-BH in the absence of Na+ to switch the
conformation of Mhp1 from inward-facing to outward-facing is
particularly signiﬁcant, since measurements of tryptophan
ﬂuorescence of the protein show that L-BH binds to the
protein in the absence of added Na+.37,47,48,51 This, in
combination with the NEM-MS data presented here, suggests
that, in the absence of Na+, L-BH binds with low aﬃnity to the
inward-facing binding site. Conversely, in the presence of added
NaCl, the measured high-aﬃnity binding reﬂects binding of L-
BH to the outward-facing conformation (Figure 4a).
Since the isolated Mhp1 in DDM appears to be largely in the
inward-facing conformation, it is probable that Na+ alone does
not aﬀect the conformational distribution since the inward-
facing species lacks the Na+-binding site present in the outward-
Figure 3. Mass spectrometry of wild-type Mhp1 after labeling with
NEM under diﬀerent conditions of substrate and/or Na+ inclusion.
NaCl additions were performed at either (a) 140 mM NaCl or (b) 1
M NaCl. (i) Deconvoluted mass distributions of Mhp1 after NEM
labeling under varied solution conditions. Note that at high
concentrations of both ligands the relative abundance of the
+2NEM peak decreases (although this is obscured in the ﬁgure).
(ii) Relative abundances of unlabeled Mhp1 (IU) relative to Mhp1 with
1 NEM label (I1NEM) in the mass spectra. Data are shown as mean ±
SEM of three independent experiments.
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facing form (as determined from X-ray crystallography).46,48
Indeed this conclusion is reinforced by molecular dynamics
simulations, in which bound Na+ is seen to leave the inward-
facing conformation rapidly.46
Next, we examined the concentration dependence of L-BH
and NaCl on the extent of NEM labeling of Mhp1. Mhp1 was
preincubated with various concentrations of NaCl (15, 50, 140,
500, or 1000 mM), L-BH was then titrated into the Mhp1-
NaCl mixture, and labeling with NEM was subsequently
performed (Figure 4b). From these experiments, a hyperbolic
increase in unlabeled Mhp1 was observed as a function of L-BH
concentration at each tested NaCl concentration (examples in
Figure 4b).
These data show a [L-BH]- and [NaCl]-dependent increase
in the amount of unlabeled Mhp1 when the other ligand is
present at a ﬁxed concentration. We ﬁtted the data obtained to
a Michaelis−Menten binding model (Figure 4b and Figure S4),
as performed for the ﬂuorescence titration experiments (Figure
4a), where the ﬁtted Km value is the apparent dissociation
constant, Kd
app. The binding model that was ﬁtted to the MS
data yields Km values that are uniformly higher than those using
ﬂuorescence (Figure S4), because the MS data reﬂect the ratio
of all inward-facing to outward-facing Mhp1 at all the possible
concentrations of [Na+]-[BH], rather than measuring only the
percent of substrate bound, which is reﬂected by the change in
tryptophan ﬂuorescence. There is no reason to expect that
these values would be similar, therefore, since diﬀerent
equilibria are being measured, as illustrated for a model
alternating access transport mechanism54,55 in Figures S5 and
S6. Thus, each technique provides complementary information
that reveals insights into the transport mechanism. The MS
data can be replotted to demonstrate the titratable eﬀect of Na+
at ﬁxed L-BH concentrations on the inward−outward
equilibrium (Figure S4). Combined, these data demonstrate a
synergistic eﬀect of Na+ and L-BH in the transition of Mhp1
from inward-facing to outward-facing. Using the estimated Km
values from all the titrations performed for the NEM-MS
experiments, it is possible to extract the binding stoichiometry
that is inducing the conformational change by plotting log Km
as a function of log(ligand concentration) (here Na+ and L-BH;
Figure 4c). These data are consistent with a 1:1 L-BH:Na+
binding stoichiometry, as the slope of the line of best ﬁt is ∼1.56
For uncharacterized transporters, such an analysis may be used
to unravel the stoichiometry of binding events that lead to
conformational changes.
Susceptibility of Cys327 to Labeling by NEM in Mhp1
Altered by Single Residue Substitutions. In order to
elucidate molecular mechanisms of transport, single point
amino acid substitutions are often made in a protein to identify
key residues in the transport process. However, it often remains
unresolved whether such mutations alter the conformational
distribution of species and/or the ability of the protein to
interconvert between inward and outward-facing forms. A
variety of mutations in Mhp1 have been made to interrogate
the functional cycle of the protein.7,47 We thus subjected a
number of these mutations to the same experimental probes
used for the wild-type protein (Figure 5). These mutants all
involved perturbing the substrate binding site of Mhp1 (Figure
5a), resulting in a reduction in uptake by Mhp1 and an
increased Km (as determined by ﬂuorescence).
47 In most cases,
mutation of residues in the L-BH binding site resulted in a
NEM-MS labeling proﬁle (in the presence of both L-BH and
NaCl) that was comprised predominantly of singly-NEM-
labeled Mhp1 (Figure 5b and Figure S7), indicating that the
protein can no longer switch from inward-facing to outward-
facing.
In two instances, for the Q42F and N318A mutations, a
strikingly diﬀerent pattern was observed (Figure 5c,d), where
all three Cys residues were labeled. These mutations
presumably destabilize the whole protein, resulting in labeling
of all three Cys residues with NEM. Consistent with this,
denaturing conditions such as adding SDS or heating Mhp1 to
80 °C in the presence of Na+ and L-BH led to exposure of all
three Cys residues in the protein and their consequent labeling
with NEM (Figure 5e−g). It is therefore likely that the
enhanced labeling of the protein seen with the N318A and
Q42F mutants was due to (partial) unfolding of the three-
dimensional structure, so that all the Cys residues became
increasingly exposed to solvent and thus more amenable to
labeling. Destabilization by such substitutions has also been
reported in two fungal transporter homologues of Mhp1, FcyB
(purine-adenine transporter), and FurD (uracil transport-
er).57,58
The NEM-MS approach could be applied to any transport
protein containing cysteine residues by incubating it with NEM,
Figure 4. Titrations of Mhp1 with L-BH monitored by ﬂuorescence
and titratable eﬀects of NEM labeling. (a) Tryptophan ﬂuorescence
quenching of Mhp1 upon titration with L-BH, in the presence of 15
mM (green), 140 mM (magenta), and 1000 mM (blue) added NaCl.
(b) Quantiﬁcation of unlabeled Mhp1 as a function of increasing [L-
BH], at the same concentrations of NaCl as those in panel a. Data are
shown as mean ± SEM of three independent measurements;
additional titrations are shown in Figure S4. (c) Plot of log Km for
either L-BH (blue) or Na+ (red) against either log[L-BH] (blue) or
log [Na+] (red). The slope of the best ﬁt line through all points was
−1.09 ± 0.07, consistent with a 1:1 Na+:L-BH stoichiometry.56
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determining the labeling ﬁngerprint by MS, and then
comparing the spectrum obtained with those of the modiﬁed
variants to determine whether any changes in conformation are
observed. Detection of unfolding does not necessarily rely on
the Cys residues being in strategically placed positions, as
would be required to monitor inward-to-outward (or the
reverse) interconversion.
■ CONCLUSION
Covalent labeling, including Cys labeling using NEM, has been
used previously to study membrane transport proteins.59 While
radiolabeled NEM was used initially to monitor labeling,60−65
more recently MS strategies have been developed for such
analyses.9,34,35 However, the application of such methods to
study alternating access mechanisms and ion−substrate
coupling has been limited.66 In several instances, NEM labeling
of Cys residues has been shown to inhibit substrate binding by
secondary active membrane transport proteins.64 The relatively
narrow range of side-chain reactivity of NEM has made this
reagent a valuable tool for the study of membrane protein
topology, for example by scanning mutagenesis approaches.60,61
Alternative covalent labeling strategies to probe membrane
protein topology are also available, such as hydroxyl radical
footprinting67−70 or hydrogen−deuterium exchange,71−73 but
such applications are limited by the need for specialized
equipment, intricate workﬂows, time scales available (including
issues with back-exchange in hydrogen−deuterium exchange
and limited reactivity of some side chains in oxidative
labeling29,67,68), and the complexity of the data analysis. Such
structural analyses, therefore, are far from routine, especially for
those interested in membrane proteins. The biochemical and
analytical methodologies employed here to study NEM-labeled
membrane proteins by MS, by contrast, are relatively simple to
perform and enable quantitation at the intact protein level,
opening up the method for application of the workﬂow
described by a broad spectrum of biochemists interested in
studying alternating access mechanisms, substrate binding, and
ion−substrate coupling. Additionally, quantitation by MS at the
intact protein level obviates the need for protease digestion to
which many membrane proteins are refractory.74
An important, unique, feature of the NEM-MS experiments
is that chemical modiﬁcation took place after the incubation
with the ligands that were expected to aﬀect the conformational
equilibrium of the protein. This sets the approach described
apart from other methods, e.g., FRET or EPR,7,10,75,76 which
require amino acid substitution and/or derivatization with
bulky probes. Membrane proteins can be refractory to
conventional analytical methods, and the added beneﬁt that
the analyses do not require the protein to retain its three-
dimensional structure during the MS measurements also
constitutes a signiﬁcant advantage of this method.
In the case of wild-type Mhp1, one Cys residue, Cys327, is
fortuitously in a position where conformational changes were
likely to aﬀect access of the thiol-reactive reagent NEM.
However, it is simple to introduce Cys residues into positions
known to be conformationally sensitive and then implement
the strategy described here to provide conformational insights.
General application of such an approach to other proteins,
including eukaryotic homologues of transporters that often
contain an abundance of Cys residues, may also require
judicious deletion of naturally occurring Cys residues or
introduction of a Cys uniquely sensitive to labeling in diﬀerent
conformational forms. Importantly, such deletions/insertions
must not alter the structure−activity relationship of the
individual protein under investigation.
Figure 5. Substitutions of individual amino acid in the ligand binding site, aﬀecting the labeling of Mhp1 by NEM. (a) Representation of the L-BH
binding site of Mhp1 in the inward-facing occluded state (PDB 4D1B).47 Key residues where substitutions have been made here are labeled. L-BH is
shown in green. (b) Relative abundances of unlabeled protein (IU) relative to protein with 1 NEM label (I1NEM) in the mass spectra for Mhp1 and
selected Mhp1 variants. “WT In” corresponds to Mhp1 in the presence of 1.25 mM 15-crown-5, and WT Out corresponds to labeling after
preincubation with 2 mM L-BH and 140 mM NaCl. For all Mhp1 variants, labeling was performed after preincubation with 2 mM L-BH and 140
mM NaCl. Where the unmodiﬁed protein was not detected upon labeling, the relative abundance values are displayed as ±1%, reﬂecting the
detection limit and signal-to-noise of the measurement (for G219S Mhp1). Values are displayed as mean ± SEM of three independent experiments.
(c−g) Deconvoluted mass distributions of (c) Q42F Mhp1, (d) N318A Mhp1, (e) WT Mhp1 (f) WT Mhp1 heated to 80 °C and (g) Mhp1 in the
presence of 0.5 % w/v SDS after NEM labeling in the presence of 15-crown-5 (1.25 mM).
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From the experiments described here we show that puriﬁed
wild-type Mhp1 in DDM is in an inward-facing conformation
and remains so when either a hydantoin substrate or Na+ is
added, but changes to outward-facing when the two are added
together in a concentration-dependent manner. This alone is an
important constraint when attempting to understand the
individual steps of the transport cycle. Equally as important is
that our experiments have illuminated the eﬀects of single
residue substitutions on the conformational state of the protein.
While only a small number of examples are given here, a wide
range of single residue mutations of Mhp1 have been generated
for study.47 Previously, information on the conformation of the
protein required crystallographic structure determination, often
impossible due to the perturbation(s) imposed by the mutation
itself, highlighting the power of NEM-MS for a simple readout
and quantiﬁcation of the diﬀerent conformational states of the
protein ensemble.
For Mhp1, three conformationally diﬀerent structures were
identiﬁed by crystallography,46−48 but in a more likely scenario,
for other proteins for which only a single structure is available,
the MS-based strategy described here could be implemented to
discriminate hypotheses about conformational changes, to
identify residues important for structural maintenance, and to
screen a number of variants quickly. Even when no structure is
available, a model of the structure of any protein and its
conformational ﬂexibility could be tested using the strategy
described, which requires only microgram quantities of protein
and provides rapid insights about the relative population of
diﬀerent conformational states that is not possible using
crystallography.
In the case of Mhp1 it was not necessarily anticipated that
the protein would remain in the inward-facing state in DDM
micelles when either L-BH or Na+ were present, nor that very
high concentrations of Na+ would be necessary to drive the
change from inward-facing to outward-facing. Moreover, it was
previously unknown which mutations would aﬀect the balance
of conformations, nor which ones would promote unfolding/
denaturing of its structure. These are all important observations
that, alongside others,7,36,39,46,47,77 illuminate our understanding
of the complete reaction cycle of this transport protein. For
many other transporters, and indeed for any protein, the NEM-
MS strategy described can be readily implemented to
interrogate conformational transitions, elucidate ion−substrate
coupling stoichiometry, screen widely for ligand speciﬁcity and
illuminate mechanistic features that have eluded character-
ization to date.
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